Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

Por Cluzeau, T, Moreilhon, C, Mounier, N, Karsenti, J-M, Gastaud, L, Garnier, G, Re, D, Montagne, N, Gutnecht, J, Auberger, P, Fuzibet, J G, Cassuto, J-P, Raynaud, S
Publicado em 2013